Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 911163103 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Vanguard Capital Management LLC 13G | 5.0% |
7/31/2026
Event 6/30/2026
|
|
|
American Century Investment Management, Inc.
13G
|
5.5% |
5/1/2026
Event 3/31/2026
|
|
| American Century ETF Trust | 5.2% | ||
| American Century Investment Management, Inc. | 5.5% | ||
| American Century Companies, Inc. | 5.5% | ||
| Stowers Institute for Medical Research | 5.5% | ||
| Vanguard Portfolio Management LLC 13G | 7.3% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 17 | 0% |
3/27/2026
Event 3/13/2026
|
|
| Vanguard Group Inc 13G/A Amendment 16 | 12.1% |
10/31/2025
Event 9/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 4 | 15.0% |
4/30/2025
Event 3/31/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 20 | 105 k | $4.72 M |
| 2026 Q2 | 377 | 60.4 M | $2.68 B |
| 2026 Q1 | 371 | 57.5 M | $2.59 B |
| 2025 Q4 | 338 | 56.2 M | $1.89 B |
| 2025 Q3 | 309 | 56.7 M | $2.13 B |
| 2025 Q2 | 298 | 60.1 M | $1.40 B |
| 2025 Q1 | 288 | 54.3 M | $1.49 B |
| 2024 Q4 | 281 | 54.0 M | $1.48 B |
| 2024 Q3 | 260 | 52.7 M | $887 M |
| 2024 Q2 | 246 | 54.4 M | $713 M |
| 2024 Q1 | 247 | 54.8 M | $630 M |
| 2023 Q4 | 272 | 54.2 M | $879 M |
| 2023 Q3 | 254 | 52.6 M | $742 M |
| 2023 Q2 | 270 | 52.6 M | $1.03 B |
| 2023 Q1 | 281 | 52.4 M | $1.38 B |
| 2022 Q4 | 299 | 55.3 M | $2.14 B |
| 2022 Q3 | 299 | 51.7 M | $1.78 B |
| 2022 Q2 | 300 | 51.1 M | $2.01 B |
| 2022 Q1 | 306 | 49.9 M | $2.06 B |
| 2021 Q4 | 308 | 47.1 M | $2.31 B |
| 2021 Q3 | 299 | 46.9 M | $2.27 B |
| 2021 Q2 | 262 | 47.5 M | $1.76 B |
| 2021 Q1 | 267 | 49.1 M | $1.62 B |
| 2020 Q4 | 246 | 52.7 M | $844 M |
| 2020 Q3 | 246 | 46.1 M | $686 M |
| 2020 Q2 | 241 | 45.0 M | $819 M |
| 2020 Q1 | 211 | 46.1 M | $423 M |
| 2019 Q4 | 209 | 45.0 M | $394 M |
| 2019 Q3 | 232 | 49.7 M | $572 M |
| 2019 Q2 | 234 | 50.0 M | $449 M |
| 2019 Q1 | 252 | 48.6 M | $643 M |
| 2018 Q4 | 260 | 54.5 M | $575 M |
| 2018 Q3 | 303 | 53.2 M | $1.59 B |
| 2018 Q2 | 333 | 52.3 M | $2.23 B |
| 2018 Q1 | 330 | 51.1 M | $2.20 B |
| 2017 Q4 | 309 | 53.8 M | $2.65 B |
| 2017 Q3 | 302 | 56.1 M | $2.33 B |
| 2017 Q2 | 288 | 55.8 M | $2.05 B |
| 2017 Q1 | 298 | 53.7 M | $2.32 B |
| 2016 Q4 | 309 | 50.3 M | $2.40 B |
| 2016 Q3 | 326 | 50.4 M | $2.02 B |
| 2016 Q2 | 329 | 50.0 M | $2.35 B |
| 2016 Q1 | 306 | 51.7 M | $2.08 B |
| 2015 Q4 | 300 | 54.7 M | $2.16 B |
| 2015 Q3 | 302 | 52.7 M | $2.56 B |
| 2015 Q2 | 310 | 53.4 M | $3.40 B |
| 2015 Q1 | 318 | 50.2 M | $3.87 B |
| 2014 Q4 | 312 | 50.6 M | $3.92 B |
| 2014 Q3 | 291 | 51.6 M | $3.17 B |
| 2014 Q2 | 290 | 51.4 M | $3.34 B |
| 2014 Q1 | 291 | 47.0 M | $3.33 B |